New Delhi: Germany’s BioNTech SE said on Monday that it signed a deal with privately held OncoC4 Inc to co-develop and commercialize its cancer antibody drug candidate. OncoC4 will get

New Delhi: Digital solutions hold the capacity to revolutionise the healthcare delivery systems. India aims to launch a global initiative on digital health as an institutional framework. This framework aims

New Delhi: The recent rise in COVID-19 cases is not a cause for concern. However, we still need to be watchful not just for COVID-19, but also because of a

New Delhi: After Corona, now the risk of a new sub-variant H3N2 is increasing as the virus is fastly spreading across the country, and its cases are also coming to

London: Digital health tools and technologies such as artificial intelligence (AI) and machine learning (ML) are expected to further integrate into the healthcare industry due to the impact of the

New Delhi: The rise in COVID-19 cases in India hasn’t been accompanied by any “unusual pattern” or “clustering,” according to an expert at the apex network of laboratories monitoring genomic

New Delhi: India registered 918 fresh COVID-19 cases in the last 24 hours. This brings the total number of active cases in the country to 6,350, representing 0.01 per cent.

Mumbai: Glenmark Pharmaceuticals has received final approval by the United States Food and Drug Administration (USFDA) for Prochlorperazine Maleate Tablets USP, 5 mg and 10 mg, the generic version of

New Delhi: Leveraging India’s presidency of the G20 and the prolific actions and commitments of previous presidencies, the Union Ministry of Health and Family Welfare and the WHO South-East Asia

New Delhi: The Union health ministry is examining the possibility of introducing a centralised recruitment for faculty and non faculty at various AIIMS across India to address the shortage of